Sunshine Biopharma Inc. - Common stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Sep 2026Filed 12/11/2026 | Jun 2026Filed 13/08/2026 | Mar 2026Filed 13/05/2026 | Sep 2025Filed 12/11/2026 | Jun 2025Filed 13/08/2026 | Mar 2025Filed 13/05/2026 | Sep 2024Filed 13/11/2025 | Jun 2024Filed 12/08/2025 |
|---|---|---|---|---|---|---|---|---|
| $9.4 | $9.3 | $8.1 | $9.4 | $9.4 | $8.9 | $8.4 | $9.3 | |
| −$1.2 | −$1.6 | −$1.2 | −$0.9 | −$1.8 | −$1.2 | −$1.2 | −$0.5 | |
| −$5.20 | −$1.15 | −$0.25 | −$38.80 | −$0.82 | −$0.44 | −$0.94 | −$43.48 | |
| 0.2 | 1.4 | 4.9 | — | 3.6 | 2.7 | 1.3 | — |
Trend